Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7954]

AACR: Investigational anticancer drug may benefit subgroup of patients with head and neck cancer

AACR: Investigational anticancer drug may benefit subgroup of patients with head and neck cancer

AACR: Study identifies potential approach to overcome breast cancer resistance to HER2-targeted therapies

AACR: Study identifies potential approach to overcome breast cancer resistance to HER2-targeted therapies

Clinical trials: clearer rules, better protection for patients

Clinical trials: clearer rules, better protection for patients

AACR: I-SPY 2 Trial identifies subset of breast cancer patients most likely to benefit from neratinib

AACR: I-SPY 2 Trial identifies subset of breast cancer patients most likely to benefit from neratinib

AACR: New antibody-drug conjugate shows early promise against all forms of melanoma

AACR: New antibody-drug conjugate shows early promise against all forms of melanoma

ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate cancer

ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate...

AACR: New drug demonstrates early promise in metastatic breast cancer

AACR: New drug demonstrates early promise in metastatic breast cancer

Largest ever melanoma study demonstrates tolerability and efficacy of vemurafenib in most aggressive form of skin cancer

Largest ever melanoma study demonstrates tolerability and efficacy of vemurafenib in most aggressive form of skin...

Use of mood stabilizing drug linked with reduced risk of developing head and neck cancer

Use of mood stabilizing drug linked with reduced risk of developing head and neck cancer

Scientists discover new protein involved in lung cancer

Scientists discover new protein involved in lung cancer

More from ecancer